Amgen sues Apotex over Sensipar generic

14-10-2016

Amgen sues Apotex over Sensipar generic

IgorUA / Shutterstock.com

Amgen has filed a complaint against Apotex for allegedly infringing a patent centring on Sensipar (cinacalcet hydrochloride) tablets.


Amgen, Apotex, Sensipar, patent, ANDA, FDA

LSIPR